Drug profile · INN
procaine hydrochloride
PROCAINE HYDROCHLORIDE
procaine hydrochloride (PROCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Associated with Milestone Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
Drug details — procaine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 2
- Programs
- 0
- Data quality
- 0.89
Quick answer
procaine hydrochloride (PROCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Associated with Milestone Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is procaine hydrochloride?
procaine hydrochloride (PROCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Associated with Milestone Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for procaine hydrochloride?
PROCAINE HYDROCHLORIDE is a marketed brand name for procaine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of procaine hydrochloride?
procaine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.